1. Home
  2. INBX
  3. INBX News

Latest Inhibrx Inc. (INBX) News on November 24, 2025

Inhibrx Reports Third Quarter 2025 Financial Results
INBX

PR Newswire

10 days ago

Inhibrx Reports Third Quarter 2025 Financial Results

LGND: Target Up On Improved Growth Outlook
INBX

Zacks Small Cap Research

14 days ago

LGND: Target Up On Improved Growth Outlook

Inhibrx Announces Participation in Upcoming Scientific Conferences
INBX

PR Newswire

20 days ago

Inhibrx Announces Participation in Upcoming Scientific Conferences

Inhibrx Biosciences’ stock soars on chondrosarcoma Phase II victory
INBX

Clinical Trials Arena

a month ago

Inhibrx Biosciences’ stock soars on chondrosarcoma Phase II victory

Inhibrx Biosciences Reports Positive Topline Results from its Registrational Trial of Ozekibart (INBRX-109) in Chondrosarcoma and Provides Updates on Colorectal Cancer and Ewing Sarcoma Expansion Cohorts
INBX

PR Newswire

a month ago

Inhibrx Biosciences Reports Positive Topline Results from its Registrational Trial of Ozekibart (INBRX-109) in Chondrosarcoma and Provides Updates on Colorectal Cancer and Ewing Sarcoma Expansion Cohorts

Inhibrx To Host Webcast Presentation of Topline Results from its Registrational Trial of Ozekibart (INBRX-109) in Chondrosarcoma and to Provide Updates on Colorectal Cancer and Ewing Sarcoma Expansion Cohorts
INBX

PR Newswire

a month ago

Inhibrx To Host Webcast Presentation of Topline Results from its Registrational Trial of Ozekibart (INBRX-109) in Chondrosarcoma and to Provide Updates on Colorectal Cancer and Ewing Sarcoma Expansion Cohorts

Owning 45% shares,institutional owners seem interested in Inhibrx Biosciences, Inc. (NASDAQ:INBX),
INBX

Simply Wall St.

a month ago

Owning 45% shares,institutional owners seem interested in Inhibrx Biosciences, Inc. (NASDAQ:INBX),

Liquidia Stock Gets Relative Strength Rating Lift
INBX

Investor's Business Daily

4 months ago

Liquidia Stock Gets Relative Strength Rating Lift

Inhibrx Reports First Quarter 2025 Financial Results
INBX

PR Newswire

6 months ago

Inhibrx Reports First Quarter 2025 Financial Results

INBX

MT Newswires

8 months ago

Inhibrx Biosciences Signs Deal With Outgoing CSO Brendan Eckelman's New Venture

Inhibrx Biosciences Announces Departure of CSO and Appointments of New CSO and President
INBX

PR Newswire

8 months ago

Inhibrx Biosciences Announces Departure of CSO and Appointments of New CSO and President

Inhibrx Biosciences Full Year 2024 Earnings: Beats Expectations
INBX

Simply Wall St.

8 months ago

Inhibrx Biosciences Full Year 2024 Earnings: Beats Expectations

Inhibrx Reports Fourth Quarter and Fiscal Year 2024 Financial Results
INBX

PR Newswire

8 months ago

Inhibrx Reports Fourth Quarter and Fiscal Year 2024 Financial Results

INBX

MT Newswires

10 months ago

Inhibrx Prospective Colorectal Cancer Treatment Shows Encouraging Results, Trial Expansion Planned

Inhibrx Biosciences Announces Preliminary Data from the Phase 1 Trial of ozekibart (INBRX-109) for the Treatment of Colorectal Cancer
INBX

PR Newswire

10 months ago

Inhibrx Biosciences Announces Preliminary Data from the Phase 1 Trial of ozekibart (INBRX-109) for the Treatment of Colorectal Cancer

Inhibrx Biosciences Announces Loan Agreement with Oxford Finance
INBX

PR Newswire

10 months ago

Inhibrx Biosciences Announces Loan Agreement with Oxford Finance

INBX

MT Newswires

a year ago

Inhibrx Biosciences Insider Bought Shares Worth $1,523,620, According to a Recent SEC Filing

The recent drop in prices must have disappointed Inhibrx Biosciences, Inc. (NASDAQ:INBX) institutional investors who own 43% of the shares
INBX

Simply Wall St.

a year ago

The recent drop in prices must have disappointed Inhibrx Biosciences, Inc. (NASDAQ:INBX) institutional investors who own 43% of the shares

Inhibrx Biosciences Reports Third Quarter 2024 Financial Results
INBX

PR Newswire

a year ago

Inhibrx Biosciences Reports Third Quarter 2024 Financial Results

Inhibrx Prevails in Trade Secret Case, Reaffirming Its Commitment to Integrity and Innovation
INBX

PR Newswire

a year ago

Inhibrx Prevails in Trade Secret Case, Reaffirming Its Commitment to Integrity and Innovation

INBX

Argus Research

a year ago

Daily – Vickers Top Buyers & Sellers for 10/08/2024

INBX

MT Newswires

a year ago

Inhibrx Biosciences Insider Bought Shares Worth $629,117, According to a Recent SEC Filing

INBX

GuruFocus.com

a year ago

Director Kristiina Vuori Purchases Shares of Inhibrx Biosciences Inc (INBX)

INBX

MT Newswires

a year ago

Inhibrx Biosciences Insider Bought Shares Worth $1,037,328, According to a Recent SEC Filing

Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
INBX

PR Newswire

a year ago

Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

INBX

MT Newswires

a year ago

Inhibrx Biosciences Insider Bought Shares Worth $4,927,580, According to a Recent SEC Filing

INBX

MT Newswires

a year ago

Inhibrx Shareholders Approve Sale of INBRX-101 Assets to Sanofi

Inhibrx Inc. Stockholders Approve Sale of INBRX-101 to Sanofi
INBX

PR Newswire

a year ago

Inhibrx Inc. Stockholders Approve Sale of INBRX-101 to Sanofi

Inhibrx, Inc. Announces Updated When-Issued Trading Date for Anticipated Spin-Off
INBX

PR Newswire

2 years ago

Inhibrx, Inc. Announces Updated When-Issued Trading Date for Anticipated Spin-Off

Inhibrx, Inc. Announces Record Date and Expected Distribution Time for Anticipated Spin-Off and the Expected Merger Effective Time for Anticipated Merger
INBX

PR Newswire

2 years ago

Inhibrx, Inc. Announces Record Date and Expected Distribution Time for Anticipated Spin-Off and the Expected Merger Effective Time for Anticipated Merger

Inhibrx, Inc. (INBX) Reports Q4 Loss, Tops Revenue Estimates
INBX

Zacks

2 years ago

Inhibrx, Inc. (INBX) Reports Q4 Loss, Tops Revenue Estimates

Inhibrx Reports Fourth Quarter and Fiscal Year 2023 Financial Results
INBX

PR Newswire

2 years ago

Inhibrx Reports Fourth Quarter and Fiscal Year 2023 Financial Results

Will Corcept (CORT) Beat Estimates Again in Its Next Earnings Report?
INBX

Zacks

2 years ago

Will Corcept (CORT) Beat Estimates Again in Its Next Earnings Report?

SoFi Stock Soars After Company Posts First-Ever Quarterly Profit
INBX

Barrons.com

2 years ago

SoFi Stock Soars After Company Posts First-Ever Quarterly Profit

Gabelli Funds to Host Pump, Valve & Water Systems Symposium at The Yale Club, New York, NY
INBX

GlobeNewswire

2 years ago

Gabelli Funds to Host Pump, Valve & Water Systems Symposium at The Yale Club, New York, NY

Forget Palantir: 2 Artificial Intelligence (AI) Stocks to Buy Instead
INBX

Motley Fool

2 years ago

Forget Palantir: 2 Artificial Intelligence (AI) Stocks to Buy Instead

Gentex Corporation (NASDAQ:GNTX) Q4 2023 Earnings Call Transcript
INBX

Insider Monkey

2 years ago

Gentex Corporation (NASDAQ:GNTX) Q4 2023 Earnings Call Transcript

Pharma Stock Roundup: JNJ Reports Q4 Earnings, SNY Inks M&A Deal With INBX
INBX

Zacks

2 years ago

Pharma Stock Roundup: JNJ Reports Q4 Earnings, SNY Inks M&A Deal With INBX

Sensient Technologies (NYSE:SXT) Has Affirmed Its Dividend Of $0.41
INBX

Simply Wall St.

2 years ago

Sensient Technologies (NYSE:SXT) Has Affirmed Its Dividend Of $0.41

Biotech Stock Roundup: GILD Down on Study Results, INBX Gains on Sanofi Deal & More
INBX

Zacks

2 years ago

Biotech Stock Roundup: GILD Down on Study Results, INBX Gains on Sanofi Deal & More

Inhibrx, Inc. (INBX) Soars 8.9%: Is Further Upside Left in the Stock?
INBX

Zacks

2 years ago

Inhibrx, Inc. (INBX) Soars 8.9%: Is Further Upside Left in the Stock?

Health Care Roundup: Market Talk
INBX

The Wall Street Journal

2 years ago

Health Care Roundup: Market Talk

These Stocks Moved the Most Today: United, 3M, Verizon, Plug Power, Johnson & Johnson, GE, and More
INBX

Barrons.com

2 years ago

These Stocks Moved the Most Today: United, 3M, Verizon, Plug Power, Johnson & Johnson, GE, and More

Inhibrx Soared 176% Over Two Months — Now, Sanofi Is Buying It
INBX

Investor's Business Daily

2 years ago

Inhibrx Soared 176% Over Two Months — Now, Sanofi Is Buying It

Inhibrx (INBX) Up 6% on Sale of Rare Disease Drug to Sanofi
INBX

Zacks

2 years ago

Inhibrx (INBX) Up 6% on Sale of Rare Disease Drug to Sanofi

Survey Reveals 55% of CXM Leaders Plan to Invest $1 Million or more in GenAI in Next 12-18 Months
INBX

Business Wire

2 years ago

Survey Reveals 55% of CXM Leaders Plan to Invest $1 Million or more in GenAI in Next 12-18 Months

Sanofi to buy Inhibrx in deal worth up to $2.2B
INBX

BioPharma Dive

2 years ago

Sanofi to buy Inhibrx in deal worth up to $2.2B

Is CNO Financial Group (CNO) Stock Undervalued Right Now?
INBX

Zacks

2 years ago

Is CNO Financial Group (CNO) Stock Undervalued Right Now?

Crinetics Pharmaceuticals Inc Insider Sells Shares
INBX

GuruFocus.com

2 years ago

Crinetics Pharmaceuticals Inc Insider Sells Shares

A Closer Look At Atlantica Sustainable Infrastructure plc's (NASDAQ:AY) Uninspiring ROE
INBX

Simply Wall St.

2 years ago

A Closer Look At Atlantica Sustainable Infrastructure plc's (NASDAQ:AY) Uninspiring ROE

Main Street Capital (MAIN) Increases Yet Falls Behind Market: What Investors Need to Know
INBX

Zacks

2 years ago

Main Street Capital (MAIN) Increases Yet Falls Behind Market: What Investors Need to Know

Arbor Realty Trust (ABR) Ascends But Remains Behind Market: Some Facts to Note
INBX

Zacks

2 years ago

Arbor Realty Trust (ABR) Ascends But Remains Behind Market: Some Facts to Note

SiTime to Present at the Needham Growth Conference on January 16, 2024
INBX

GlobeNewswire

2 years ago

SiTime to Present at the Needham Growth Conference on January 16, 2024

What Is Nova Ltd.'s (NASDAQ:NVMI) Share Price Doing?
INBX

Simply Wall St.

2 years ago

What Is Nova Ltd.'s (NASDAQ:NVMI) Share Price Doing?

Is Array Technologies Stock a Top Buy on the Dip in 2024?
INBX

Motley Fool

2 years ago

Is Array Technologies Stock a Top Buy on the Dip in 2024?

Is There Now An Opportunity In Rapid7, Inc. (NASDAQ:RPD)?
INBX

Simply Wall St.

2 years ago

Is There Now An Opportunity In Rapid7, Inc. (NASDAQ:RPD)?

Brookfield Acknowledges Result of the Origin Energy Shareholder Vote
INBX

GlobeNewswire

2 years ago

Brookfield Acknowledges Result of the Origin Energy Shareholder Vote

Here's Why Prestige Consumer Healthcare (PBH) is a Strong Value Stock
INBX

Zacks

2 years ago

Here's Why Prestige Consumer Healthcare (PBH) is a Strong Value Stock

Apple Hospitality REIT Reports Results of Operations for Third Quarter 2023
INBX

Business Wire

2 years ago

Apple Hospitality REIT Reports Results of Operations for Third Quarter 2023

Privia Health Group, Inc.'s (NASDAQ:PRVA) P/S Still Appears To Be Reasonable
INBX

Simply Wall St.

2 years ago

Privia Health Group, Inc.'s (NASDAQ:PRVA) P/S Still Appears To Be Reasonable

Share on Social Networks: